16.10.2023 • News

Albemarle Withdraws Bid to Acquire Liontown Resources

US specialty chemicals company Albemarle has announced that it will not pursue a binding agreement to purchase Liontown Resources and has formally withdrawn its non-binding offer.

On Sep. 3, Liontown had received a revised conditional and non-binding indicative proposal from Albemarle to acquire all of the outstanding shares in Liontown for A$3.00 in cash per share via scheme of arrangement. The revised proposal valued Liontown at A$6.6 billion ($4.3 billion) on an equity value basis.

"Our engagement with the Liontown team has been meaningful and productive. We appreciate the level of cooperation we have received, and we thank the entire team for their efforts," said Kent Masters, CEO of Albemarle. "That said, moving forward with the acquisition, at this time, is not in Albemarle's best interests."

The stated that growing complexities associated with the proposed transaction were a factor in its decision.

Albemarle said it will continue to pursue its long-term growth strategy and that its capital allocation priorities remain high-yield organic and inorganic growth, maintaining the company's financial flexibility and investment-grade credit rating, and funding its dividends.

Albemarle Withdraws Bid to Acquire Liontown Resources

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.